Used as an intermediate in the synthesis of nitroimidazole-based pharmaceuticals, particularly in the development of antimicrobial and antiparasitic agents. Its structure supports bioactivity against anaerobic bacteria and certain protozoa. Commonly employed in research settings to design new derivatives with improved pharmacokinetic properties. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies due to the presence of reactive functional groups that allow further chemical modifications.